Moving Toward Objective Diagnosis in Fibromyalgia: Emerging Biomarkers and Digital Phenotyping Tools

Area of Science:

• Neuroscience
• Medical diagnostics

Background:

• Fibromyalgia is a complex chronic pain disorder with subjective diagnostic criteria leading to delays.
• Current diagnosis relies on symptom assessment and exclusion, hindering timely intervention.

Purpose of the Study:

• To explore objective biomarkers for fibromyalgia diagnosis.
• To investigate the potential of digital phenotyping for improved diagnostic precision.

Main Methods:

• Review of recent research on neuroimaging, cerebrospinal fluid/blood biomarkers, and neuroendocrine/autonomic patterns.
• Analysis of metabolomics and transcriptomics data for molecular insights.
• Evaluation of digital health tools like wearable sensors and machine learning for data collection.

Main Results:

• Neuroimaging, inflammatory markers, and autonomic patterns show potential as objective fibromyalgia indicators.
• Metabolomic and transcriptomic studies reveal molecular signatures of the condition.
• Digital phenotyping enables continuous, real-world data capture for personalized characterization.

Conclusions:

• Integrating biological and digital metrics can shift fibromyalgia diagnosis from subjective to objective.
• This data-driven approach promises earlier diagnosis and enhanced therapeutic outcomes for fibromyalgia patients.